Sign in
4

Changes in Ownership

SpyGlass Pharma, Inc. Filed Acc 0001231919-26-000122

Options or other derivatives

  • Director acquired 27,400 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

RA CAPITAL MANAGEMENT, L.P. · Director

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2026-02-05 Grant or award : show line 1 in the form Stock Option (right to buy) +27,400 27,400 I
Loading xslF345X05/form4-02092026_100237.xml…